305 ILCS 5/5-54: Coverage for proteomic blood tests.

(a) The medical assistance program shall provide coverage and reimbursement for a prescribed proteomic blood test, with clinical trial proof of improved infant outcomes published in peer-reviewed journals, that identifies and quantifies the risk of preterm birth for an individual pregnancy.

(b) The medical assistance program shall provide coverage and reimbursement for remote patient management services, including telecare management and remote physiologic monitoring, that address maternity and postpartum care access challenges for individualized care delivery by licensed providers. Only remote patient management services with evidence of improved patient care shall be covered and reimbursed under this subsection.